Mersana Therapeutics(MRSN) - 2024 Q4 - Earnings Call Transcript

Mersana Therapeutics, Inc. Q4 2024 Earnings Conference Call March 3, 2025 8:00 AM ET Company Participants Jason Fredette - SVP, IR Martin Huber - President & CEO Brian DeSchuytner - CFO & COO Conference Call Participants Yen-Der Li - Leerink Partners Charles Zhu - LifeSci Capital Paul Jeng - Guggenheim Andy Hsieh - William Blair Asthika Goonewardene - Truist Operator Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year End 2024 Conference Call. Currently all participants are in a listen ...